Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex

被引:26
作者
Muraki, I [1 ]
Inoue, T [1 ]
Hashimoto, S [1 ]
Izumi, T [1 ]
Ito, K [1 ]
Koyama, T [1 ]
机构
[1] Hokkaido Univ, Sch Med, Dept Psychiat, Kita Ku, Sapporo, Hokkaido 0608638, Japan
关键词
citalopram; in vivo microdialysis; lithium; serotonin; SSRI;
D O I
10.1046/j.1471-4159.2001.00091.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effect of citalopram [a selective serotonin (5-HT) reuptake inhibitor; SSRI] and MKC-242 (a selective 5-HT1A agonist), following treatment with subchronic lithium (p.o., 1 week) on extracellular 5-HT concentrations in the medial prefrontal cortex (mPFC). Acute treatment with citalopram (3 and 30 mg/kg) led to significant increases in extracellular 5-HT concentrations. The subchronic lithium group showed significantly higher basal levels of extracellular 5-HT than normal diet controls. Acute citalopram (3 and 30 mg/kg) treatment together with subchronic lithium treatment showed significant increases in the extracellular 5-HT concentrations, compared with citalopram treatment alone. Acute MKC-242 (1 mg/kg) treatment showed significant decreases in extracellular 5-HT concentrations, in both the normal diet and lithium diet groups to the same extent. The addition of lithium did not change the effect of the 5-HT1A agonist on extracellular 5-HT concentrations. This study suggests that lithium augmentation of the antidepressant effect of SSRI is mediated by the additional increases in extracellular 5-HT concentrations following the co-administrations of lithium and SSRI.
引用
收藏
页码:490 / 497
页数:8
相关论文
共 49 条
[21]   Subchronic lithium treatment increases the anxiolytic-like effect of mirtazapine on the expression of contextual conditioned fear [J].
An, Yan ;
Inoue, Takeshi ;
Kitaichi, Yuji ;
Nakagawa, Shin ;
Wang, Ce ;
Chen, Chong ;
Song, Ning ;
Kusumi, Ichiro .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 747 :13-17
[22]   Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex [J].
Varea, Emilio ;
Blasco-Ibanez, Jose Miguel ;
Gomez-Climent, Maria Angeles ;
Castillo-Gomez, Esther ;
Crespo, Carlos ;
Martinez-Guijarro, Francisco Jose ;
Nacher, Juan .
NEUROPSYCHOPHARMACOLOGY, 2007, 32 (04) :803-812
[23]   Chronic Fluoxetine Treatment Increases the Expression of PSA-NCAM in the Medial Prefrontal Cortex [J].
Emilio Varea ;
José Miguel Blasco-Ibáñez ;
María Ángeles Gómez-Climent ;
Esther Castillo-Gómez ;
Carlos Crespo ;
Francisco José Martínez-Guijarro ;
Juan Nácher .
Neuropsychopharmacology, 2007, 32 :803-812
[24]   Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex [J].
Bymaster, FP ;
Zhang, W ;
Carter, PA ;
Shaw, J ;
Chernet, E ;
Phebus, L ;
Wong, DT ;
Perry, KW .
PSYCHOPHARMACOLOGY, 2002, 160 (04) :353-361
[25]   Effect of amphetamine on extracellular acetylcholine and monoamine levels in subterritories of the rat medial prefrontal cortex [J].
Hedou, G ;
Homberg, J ;
Martin, S ;
Wirth, K ;
Feldon, J ;
Heidbreder, CA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 390 (1-2) :127-136
[26]   Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex [J].
Bland, ST ;
Hargrave, D ;
Pepin, JL ;
Amat, J ;
Watkins, LR ;
Maier, SF .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (09) :1589-1596
[27]   Stressor Controllability Modulates Stress-Induced Dopamine and Serotonin Efflux and Morphine-Induced Serotonin Efflux in the Medial Prefrontal Cortex [J].
Sondra T Bland ;
David Hargrave ;
Julie L Pepin ;
Jose Amat ;
Linda R Watkins ;
Steven F Maier .
Neuropsychopharmacology, 2003, 28 :1589-1596
[28]   Evidence for Tonic Control by the GABAA Receptor of Extracellular D-Serine Concentrations in the Medial Prefrontal Cortex of Rodents [J].
Umino, Asami ;
Ishiwata, Sayuri ;
Iwama, Hisayuki ;
Nishikawa, Toru .
FRONTIERS IN MOLECULAR NEUROSCIENCE, 2017, 10
[29]   CITALOPRAMS ABILITY TO INCREASE THE EXTRACELLULAR CONCENTRATIONS OF SEROTONIN IN THE DORSAL RAPHE PREVENTS THE DRUGS EFFECT IN THE FRONTAL-CORTEX [J].
INVERNIZZI, R ;
BELLI, S ;
SAMANIN, R .
BRAIN RESEARCH, 1992, 584 (1-2) :322-324
[30]   Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity [J].
Calcagno, E. ;
Canetta, A. ;
Guzzetti, S. ;
Cervo, L. ;
Invernizzi, R. W. .
JOURNAL OF NEUROCHEMISTRY, 2007, 103 (03) :1111-1120